News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MacroGenics, Inc. (MGNX) to Ring the NASDAQ Stock Market Closing Bell in Celebration of IPO



10/10/2013 9:38:18 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ADVISORY, Oct. 10, 2013 (GLOBE NEWSWIRE) -- What: MacroGenics, Inc. [MGNX], a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, will visit the NASDAQ MarketSite in Times Square in celebration of its October 10 initial public offering (IPO) on The NASDAQ Stock Market.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES